FTC Clears AbbVie To Proceed With $10.1B ImmunoGen Buy
The 30-day waiting period for U.S. antitrust enforcers to review AbbVie's $10.1 billion purchase of ImmunoGen came and went without a move to deepen the investigation or challenge the deal, clearing...To view the full article, register now.
Already a subscriber? Click here to view full article